Loading...

Leverage Shares 3x Long Moderna (MRNA) ETC

MRN3.L•LSE
Financial Services
Asset Management - Leveraged
£16.46
£1.25(8.22%)

Leverage Shares 3x Long Moderna (MRNA) ETC (MRN3.L) Stock Overview

Explore Leverage Shares 3x Long Moderna (MRNA) ETC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap834.5K
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Week$10.47
1 Month$9.16
3 Months$5.32
1 Year TargetN/A

MRN3.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Leverage Shares 3x Long Moderna (MRNA) ETC (MRN3.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 74.49, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 834.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

74.49RSI (14)
1.67MACD
29.58ADX
Stats data is not available for MRN3.LStats details for MRN3.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MRN3.LAnalyst Recommendations details for MRN3.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

The Leverage Shares 3x Long Moderna (MRNA) ETP Securities seeks to track the iSTOXX Leveraged 3x MRNA Index, which is designed to provide 3x the daily return of Moderna Inc. stock, adjusted to reflect the fees and costs of maintaining a leveraged position in the stock

Founded

2021

Frequently Asked Questions

;